Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

Notice of Intent to Sole Source – University of Maryland Medical Center

Active
26-007059Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health - CcView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

MD, 20892, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health - Cc
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health - Cc
View Agency Profile
Office AddressBETHESDA, MD, 20892, USA
Contacts
Kristin Nagashima
contact@example.gov

Full Description

Show more

The National Institutes of Health (NIH) Clinical Center (CC) seeks a contract with University of Maryland Medical Center at Baltimore (UMB) to provide the patient population to develop a biorepository of patients suspected of or diagnosed with pulmonary hypertension (PH). The objective is to collect blood samples, demographics, clinical assessments, and outcome data in enrolled subjects. These samples will allow us to do translational research across all the World Symposium on PH groups.



•             Product Service Code: 5417 – Scientific Research and Development Services


•             NAICS Code: 541714 – Research and Development in Biotechnology


•             Place of Performance: Bethesda, MD 20892 USA



POTS: 26-007059



Description:



This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued and quotations will not be requested.



The National Institutes of Health (NIH) intends to award a fixed price purchase order to the University of Maryland Medical Center, LLC, located at 250 West Pratt St, 24th Floor, Baltimore, MD 21201, on a firm fixed price sole source award basis to provide the required biorepository of patients to the National Institutes of Health.




Funding for the research to be completed with the patient samples obtained through this contract is from the 2026 Research Award for Staff Clinicians (RASCL) Award to the NIH program. For the initial studies, a local PH center of excellence is required that has an institution affiliation with the IC. Thus, in order to maintain the integrity of the research plan and adhere to the proposed work that received funding, competition will be limited for this project.



This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.



Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.



Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by July 28, 2026 at 3pm EST.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Illumina Reagent Kits
Naval Medical Research Center

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 541714
New
Federal
Battlefield Pain Management – AnalgesicThis solicitation under the Prototype Other Transaction Authority (10 U.S.C. § 4022) seeks innovative analgesic solutions for battlefield use, with the goal of achieving FDA approval for a single-use product intended to manage acute moderate to severe pain in combat settings. The product must be rapid to administer, compact in size and weight for individual carrying, and capable of functioning without refrigeration across extreme temperatures ranging from -25°C to 45°C while maintaining a 2-3 year shelf life at controlled room temperature. It must comply with USP <659> and MIL-STD-810 environmental standards, adhere to 21 CFR Part 820 quality system requirements for labeling and packaging, and meet strict physiological limits including no more than a 20% reduction in blood pressure, heart rate, or clotting ability, with only minor, non-ventilation-required airway changes. The product must be classified as a DEA Schedule II or higher controlled substance and may be delivered via nasal spray or autoinjector. The effort spans eight years, divided into three phases: three years for Chemistry Manufacturing Controls and stability studies, two years for non-clinical enabling studies, and three years for clinical trials and human factors testing culminating in potential EUA submission. The contract is structured as an Other Transaction Agreement exempt from FAR and DFARS, except where explicitly referenced, and is not subject to Bayh-Dole provisions. Proposals must demonstrate at least one of three pass/fail conditions: inclusion of a significant nontraditional defense contractor or nonprofit research institution, all non-federal participants being small businesses or nontraditional contractors, or at least one-third of project costs being privately funded. Evaluation focuses on technical approach, management strategy, and cost, with no assigned weights provided. Submission requires three clearly organized volumes in searchable PDF format, accompanied by a Microsoft Project plan, with strict formatting rules prohibiting embellishments. All participants must be registered in SAM with an active UEI and CAGE code, and must include NAICS code 541714. Compliance with prohibitions on malign foreign talent programs is mandatory, requiring certification and disclosure of foreign affiliations, ownerships, and funding sources. Payment occurs through WAWF using NPI, cost vouchers, or invoices tied to CLINs and ACRNs, with acceptance managed by an Agreement Officer Representative. Data deliverables, including CMC reports, clinical study outcomes, and regulatory filings, are governed by CDRL and DID attachments
Defense Health Agency

POSTED

1 day ago

DEADLINE

in 21 days
View Details
NAICS: 541714
New
Federal
Development of Light-Responsive Artificial Cells using Plant-Based Photoreceptor SystemsThe United States Army Corps of Engineers Engineer Research and Development Center Construction Engineering Research Laboratory is seeking to develop light-responsive artificial cells by integrating plant-derived UVR8 photoreceptor systems into synthetic biology platforms, using high-throughput protein engineering and AI-assisted structural refinement to create programmable, pseudo-living systems activated by environmental light stimuli. The project aims to advance foundational science in synthetic biology by leveraging Bioconscientia, LLC’s uniquely specialized expertise in UVR8 photoreceptor technology, which enables precise sensing of UV-B light in a manner unmatched by other entities. Due to the highly specialized nature of the required research and Bioconscientia’s irreplaceable knowledge of existing experimental data and technical pathways, the government intends to award a sole-source contract to this vendor under RFO FAR 12.102(a), with an anticipated award date of September 30, 2026. This presolicitation notice, issued under FAR Part 5.101(a) with solicitation number W9132T26QA015 and NAICS code 541714, does not constitute a formal request for proposals or a competitive procurement, nor is it a set-aside. Interested parties may submit capability statements to CERL-CT-QUOTES@USACE.ARMY.MIL by July 31, 2026, to be reviewed for potential technical equivalency, but submission does not guarantee a change to the government’s acquisition strategy. The government retains full discretion to proceed with sole-source award regardless of responses received. All work will be performed in Champaign, Illinois, and the primary point of contact for submissions is Lurline L. Simmons, with Andrea J. Thomas serving as the contracting officer. No telephone inquiries will be accepted.
W2R2 Construction Engrg Labor

POSTED

2 days ago

DEADLINE

in 7 days
View Details
NAICS: 541714
New
Federal
AI/ML and Data Analytics for Cardiovascular Device Validation
FDA Office Of Acq Grant Svcs

POSTED

3 days ago

DEADLINE

in 4 days
View Details
NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is soliciting collaborative participation through a continuous, open Participant Basic Agreement (PBA) under the HEALER portfolio to advance next-generation, threat-agnostic host-directed therapeutics designed to enhance physiological resilience against CBRN threats. This initiative targets five critical biological systems—neurological protection, respiratory stabilization, immune modulation, hematologic and vascular function, and cellular stress and repair pathways—with the goal of developing dual-use medical countermeasures that serve both military and civilian critical care needs. The program invites two categories of collaborators: therapeutic developers with candidates that modulate host response mechanisms and drug development support providers including CROs and CDMOs with capabilities in preclinical testing, clinical trial execution, cGMP manufacturing, regulatory strategy, and advanced modeling. Submission requires a white paper of no more than five pages excluding a cover page, detailing product mechanism of action, efficacy data from validated animal models, regulatory status such as IND experience and clinical trial history, manufacturing capacity and scale-up plans, and company profile for therapeutic developers, or core capabilities and infrastructure for service providers. All participants must express willingness to collaborate with other PBA holders to foster an integrated development ecosystem. The solicitation, issued under statutory authority of 10 U.S.C. §§4021–4023, operates outside the Competition in Contracting Act and does not follow traditional procurement or evaluation frameworks, eliminating standard contract clauses, formal evaluation factors, pricing structures, or submission deadlines. Instead, awards are made at the government’s discretion through a non-traditional acquisition mechanism designed to accelerate innovation. Technical and administrative inquiries are directed to Hunter Robinson and Alexander Mayatte at the U.S. Army’s Aberdeen Proving Ground, Maryland office. Participation prerequisites include current registration in the System for Award Management (SAM), compliance with FDA regulatory pathways, and adherence to cGMP standards for manufacturing. While no specific delivery dates, FOB terms, inspection criteria, or cost estimates are defined, performance is expected to align with the mission of CPE CBRND to enable the Joint Force to operate effectively in CBRN-contested environments. Intellectual property considerations, teaming arrangements, and the scalability of therapeutic candidates are central to selection, with no socioeconomic or size status certifications required. The structure prioritizes agility, collaboration, and cross-sector innovation over rigid compliance, enabling a dynamic pipeline of medical countermeasures capable of addressing evolving biological threats through sustained host resilience.
W6QK Acc-Apg

POSTED

3 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
Non-Optical Methods for High Speed Protein ControlDARPA’s Biological Technologies Office is seeking innovative solutions through the ERIS Marketplace to develop a new class of rapidly switchable, non-optogenetic protein domains capable of enabling real-time, massless control of cellular processes. The goal is to create a robust, modular molecular tool that responds to non-optical external signals such as magnetic fields or focused ultrasound, allowing precise regulation of protein function across cell membranes without relying on light or chemicals. Proposed solutions must achieve activation and deactivation kinetics of no more than two seconds, demonstrate reliable performance through at least 300 repetitive cycles in living cells, and function effectively in both split-protein dimerization and allosteric conformational configurations. This effort explicitly excludes any modifications or enhancements to existing optogenetic, light-based, or chemical systems. The anticipated contract value is $400,000 for a 12-month performance period, with awards being made on a rolling basis as solutions are evaluated, and the government reserves the right to issue awards before the December 8, 2026 submission deadline. Proposals must be submitted via the DARPA Connect ERIS Portal as a video that follows the required title format, or existing awardable solutions may be flagged for consideration by emailing ERIS@darpa.mil with specific subject and body requirements. Evaluation will focus on four core areas: a deep understanding of the problem space and current limitations in fields like sonogenetics and magnetogenetics, a significant technical leap in achieving rapid and repeatable protein control, demonstrated expertise in synthetic biology, protein engineering, and biophysics with a proven track record of quantitative in vivo characterization, and the potential of the solution to become a foundational tool in synthetic biology with broad applications in defense-relevant areas such as biomanufacturing, cell-based therapeutics, and biosensing. All submissions are subject to the ERIS assessment process, which serves as a mandatory pass/fail gate—only solutions deemed awardable by this process will be considered for BTO award. The procuring agency is the Department of Defense through DARPA’s Arlington, VA office, and all participants must comply with the ERIS Master Solicitation requirements available via SAM.gov.
Defense Advanced Research Projects Agcy

POSTED

3 days ago

DEADLINE

in 5 months
View Details
NAICS: 541714
New
Grant
Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration AwardThe Congressionally mandated Clinical and Translational Science Awards (CTSA) Program aims to accelerate the translation of scientific discoveries into practical treatments, diagnostics, and health interventions that enhance patient and public health by funding a national network of academic medical centers. This network provides essential infrastructure, expertise, training, and collaborative platforms needed to move research from the laboratory into clinical practice and community health settings. The current opportunity is a forecast for a limited competition soliciting applications for the Collaborative and Innovative Acceleration Award, designed to support the development and implementation of novel approaches, technologies, or models that amplify the impact of translational research and expedite the delivery of effective therapies to all populations. Funding is authorized under Sections 301 and 405 of the Public Health Service Act, and governed by Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. Eligible organizations may apply under this limited competition, and proposals will undergo standard National Institutes of Health peer review, with funding awarded only to meritorious applications. The announcement is issued by the National Institutes of Health, under the Department of Health and Human Services, with specific inquiries directed to the Division of Clinical Innovation at NCATS. The forecast was posted on July 20, 2026, and further details can be accessed through the official grants.gov listing, though no set-aside type, NAICS code, or specific place of performance is indicated.
National Institutes Of Health

POSTED

4 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Federal
On-Site Technical Deployment and Integration
FDA Office Of Acq Grant Svcs

POSTED

7 days ago

DEADLINE

in 8 days
View Details
NAICS: 541714
Federal
Hypoxia Chamber ServicesNASA Johnson Space Center is soliciting offers for Hypoxia Chamber Services under solicitation number 80JSC026Q0008 to support research on the physiological, cognitive, and clinical effects of mild hypobaric hypoxia as part of the Artemis Program. The contract requires comprehensive services including infrastructure, personnel, training, materials, food, supplies, and operational support necessary to conduct controlled hypoxia experiments. This is a combined synopsis and solicitation issued under FAR Subpart 12.6, with no written solicitation to follow, and all information is contained within the posted notice and attachments, particularly Attachment A for the Performance Work Statement and Attachment D for additional submission requirements. The NAICS code is 541714 with a size standard of 1,000 employees, and offerors must self-certify their size status. Evaluation will prioritize Technical Acceptability and Past Performance as significantly more important than Price, though Price becomes increasingly relevant when proposals are closely matched in technical merit. All submissions must include completed representations and certifications per FAR 52.212-3 and comply fully with FAR 52.212-1 and 52.212-4. Proposals must be submitted electronically via email to the designated NASA contacts no later than 1:00 PM CST on August 24, 2026, with questions due by July 29, 2026. The Government assumes no responsibility for electronic submission failures, and late submissions will be rejected per FAR provisions. The place of performance is Houston, Texas, and the Ombudsman clause is applicable for dispute resolution.
NASA Johnson Space Center

POSTED

8 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
Grant
Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain BarrierThe Eunice Kennedy Shriver National Institute of Child Health and Human Development is advancing its mission to improve maternal, fetal, and child health by launching a second phase of the Transporter Elucidation Network, focused on understanding how biological transporters and local metabolic processes regulate exposure to nutrients, medications, microbiome-derived compounds, and environmental chemicals across critical perinatal barriers. This initiative will develop comprehensive multi-barrier frameworks that connect the maternal gut, placenta, lactating mammary epithelium, infant gut, and infant blood-brain barrier, building on prior organ-specific research to create standardized models, resources, and prototype multi-compartment systems that reflect the dynamic interplay of transporters, their polarity, kinetics, and biotransformation capacities during pregnancy, lactation, and infant development. The goal is to deepen mechanistic insights into how these systems influence nutrient delivery, drug distribution, and neurodevelopmental outcomes in early life. This phase will establish community-wide resources to support integrated studies of perinatal exposure, risk assessment, and targeted interventions across linked maternal-fetal-infant systems, while strengthening collaboration among researchers and accelerating the sharing of tools and data. Emphasis is placed on human-based and developmentally relevant models to ensure biological accuracy and translational impact. The effort also aims to cultivate a next-generation workforce skilled in transporter science, fostering innovation in pediatric pharmacology and neonatal health. Authorized under 42 U.S.C. § 241, the initiative is being led by the Obstetric and Pediatric Pharmacology and Therapeutics Branch of NICHD, with inquiries directed to their designated point of contact, and the opportunity was publicly forecasted on July 16, 2026.
National Institutes Of Health

POSTED

8 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Federal
Advanced Prebreathe and Thermal Monitoring Studies
NASA Johnson Space Center

POSTED

9 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
Federal
Hypobaric Chamber Pilot StudiesNASA Johnson Space Center is soliciting offers for pilot chamber testing facilities capable of conducting hypobaric Decompression Sickness (DCS) studies under solicitation number 80JSC026Q0006, issued as a combined synopsis and solicitation per FAR Part 12 for commercial products and services. The requirement calls for three test days of data collection and recording following established research protocols, with detailed specifications outlined in Attachment A – Statement of Work and additional submission criteria in Attachment D dated July 15, 2026. The solicitation is open to all responsible sources without set-aside restrictions, and offerors must declare their size status under NAICS code 541714 with a 1,000-employee size standard. Evaluation of proposals will prioritize technical acceptability, followed by past performance, and then price, as specified in FAR 52.212-2. Offers must comply with applicable clauses including FAR 52.212-1, 52.212-2, and 52.212-4, as well as NASA-specific clauses such as the Ombudsman provision. All submissions must be delivered electronically to Tracy.L.Quintanilla@nasa.gov and Katelyn.R.Jaime@nasa.gov no later than August 24, 2026, at 1:00 p.m. Central Time. Questions must be submitted via email by July 29, 2026, same time, with no telephone inquiries accepted. Prospective offerors are encouraged to notify the point of contact of their intent to respond, and it is the offeror’s responsibility to download all documents from SAM.gov and ensure timely submission, as late or incomplete offers will be rejected in accordance with FAR provisions.
NASA Johnson Space Center

POSTED

9 days ago

DEADLINE

in about 1 month
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health - Cc

Same awarding agency

NAICS: 339112
New
Federal
Notice of Intent to Sole Source – Bio-Rad Laboratories, Inc.The National Institutes of Health Clinical Center’s Department of Laboratory Medicine intends to award a sole source fixed-price purchase order to Bio-Rad Laboratories, Inc. for the Bio-Rad CFX Opus 96 Real-Time PCR System and associated reagents, to be delivered to Bethesda, Maryland. This procurement falls under simplified acquisition procedures as defined in FAR Part 13, allowing for non-competitive award because Bio-Rad is the only source reasonably available to fulfill the specific technical requirements necessary for ongoing research funded by the 2026 Research Award for Staff Clinicians. The equipment will be used to process patient samples in alignment with an approved research plan requiring institutional affiliation and technical continuity, justifying the absence of competitive bidding. The transaction is classified under Product Service Code 6515 and NAICS Code 339112, and the funding source is explicitly tied to internal NIH program funding. Although this is a notice of intent and not a formal solicitation, the government is inviting industry input prior to finalizing the award, with all comments due by July 29, 2026, directed to Kristin Nagashima at the NIH Office of Purchasing and Contracts. No formal quotations will be requested, and the decision to proceed without competition rests solely with the contracting officer under the provisions of FAR 13.106-1(b)(1), which permits sole source awards below the simplified acquisition threshold when unique circumstances limit the availability of alternative suppliers. The purchase will be executed under contract number 26-007652, and the performance location is confirmed as the NIH Clinical Center in Bethesda, Maryland.
Surgical and Medical Instrument Manufacturing

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 339112
Federal
Notice of Intent to Sole Source – Bayer HealthcareThe National Institutes of Health Clinical Center intends to sole source a firm fixed price purchase order to Bayer Healthcare LLC for three upgrades to existing CT contrast injectors located in its Radiology and Imaging Sciences Department in Bethesda, Maryland. These upgrades are necessary to maintain FDA compliance, ensure the proper calibration of life-critical safety features, and guarantee seamless integration with the existing CT imaging systems, as the proprietary technology used in the current injectors can only be serviced by the original equipment manufacturer. The acquisition falls under Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures, which permits sole source awards when only one source is reasonably available, and it is exempt from full competition requirements due to the nature of the equipment and the urgency of maintaining operational safety and regulatory standards. The contract is classified under Product Service Code 6515 and NAICS Code 339112, and the performance location is clearly designated as Bethesda, MD. This is a notice of intent, not a solicitation, and no formal request for quotations will be issued. Interested parties are invited to submit comments regarding their capabilities prior to the closing date of July 24, 2026, at 5:00 PM EST, though the government retains full discretion over whether to proceed with the sole source award based on feedback received. All submissions must reference solicitation number 26-007180 and be sent to Kristin Nagashima, Contract Specialist, at kristin.nagashima@nih.gov. The award will be made directly to Bayer Healthcare LLC, located at 100 Bayer Blvd, Whippany, NJ 07981, without competitive bidding, as the technology involved is exclusive to the manufacturer and critical for the continued safe and effective operation of diagnostic imaging services at the NIH Clinical Center.
Surgical and Medical Instrument Manufacturing

POSTED

8 days ago

DEADLINE

in about 9 hours
View Details
NAICS: 339112
Federal
Notice of Intent to Sole Source – Bio-Techne Sales CorporationThe National Institutes of Health Clinical Center intends to award a sole source fixed price purchase order to Bio-Techne Sales Corporation for the procurement of a single Pala single cell dispenser with part number NI006-R, along with onsite installation and training services, to support hematology clinical research at its Bethesda, Maryland facility. This action is justified under FAR Part 13 Simplified Acquisition Procedures, which permits non-competitive awards when only one source is reasonably available; Bio-Techne is identified as the exclusive provider capable of delivering the required equipment and associated accreditation services for healthcare organizations nationwide. The purchase falls below the simplified acquisition threshold and is exempt from standard competition requirements under FAR Part 6. The contract is governed by Product Service Code 6515 for medical instruments and equipment and falls under NAICS Code 339112 for surgical and medical instrument manufacturing. Delivery and performance will occur at the NIH Clinical Center in Bethesda, MD 20892. This notice serves solely as an announcement of intent and does not constitute a solicitation for quotes, and no formal bid process will be initiated. Interested parties may submit responses to provide input on potential alternatives prior to the deadline of July 24, 2026 at 10 a.m. EST, though the government retains full discretion to proceed without competition. All communications should be directed via email to Kristin Nagashima, Contract Specialist at the NIH Clinical Center Office of Purchasing and Contracts.
Surgical and Medical Instrument Manufacturing

POSTED

8 days ago

DEADLINE

in about 2 hours
View Details
NAICS: 339113
Federal
Notice of Intent to Sole Source – Disorb SystemsThe National Institutes of Health, through its Critical Care Medicine Department, intends to sole-source a one-time purchase of single-use aScope 5 Bronchoscopes from Disorb Systems, Inc., to ensure uninterrupted emergent and diagnostic bronchoscopy services for adult and pediatric patients in the Clinical Center’s ICU. The equipment is essential for maintaining clinical operations and data integrity, as it must interface directly with existing NIH electronic medical record systems using proprietary hardware and software protocols that are not compatible with any other available products. Substituting an alternate device would require extensive system modifications, revalidation, and retraining, posing significant operational and clinical risks. The acquisition will be conducted under FAR Part 13 Simplified Acquisition Procedures, exempting it from full competition requirements, as Disorb Systems is the only source capable of meeting the technical and compatibility specifications. The purchase falls under the simplified acquisition threshold and is classified under NAICS code 339113 with a product service code of 6515, and performance is set for Bethesda, MD. Interested parties may submit comments prior to the July 24, 2026 deadline to the designated Contract Specialist at NIH, though the government retains full discretion to proceed without competition based on the determination of sole source availability.
Surgical Appliance and Supplies Manufacturing

POSTED

8 days ago

DEADLINE

in about 4 hours
View Details
NAICS: 493110
Federal
Notice of Intent to Sole Source – Storage and shredding services for sensitive patient-related materialsThe National Institutes of Health (NIH) Clinical Center has issued a Notice of Intent for a sole-source procurement under the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures. This procurement covers secure storage and shredding services for sensitive patient-related materials generated by the Radiology and Imaging Services Division (RADIS/CC). The contract is intended to maintain and manage approximately 14,000 linear feet of archived film records accumulated over 20 years, continuing the existing relationship with Iron Mountain, a recognized industry leader in records management and secure shredding. This sole-source action is justified based on Iron Mountain’s unique capabilities and the prohibitive costs and operational disruption that would arise from transitioning these extensive patient records to another provider. The contract includes a base year plus four option years, enabling service continuity for up to five years, with an estimated potential contract ceiling under FAR 13.500(c) of up to $9 million or $15 million, although specific pricing details have not been disclosed. The acquisition is conducted in accordance with FAR 8.405-6 for limited-source procurements under the Federal Supply Schedule program, exempting it from full competition requirements under FAR Part 6. The contract emphasizes confidentiality, secure handling, and compliant shredding of protected health information in line with HIPAA standards, although no specific technical or packaging standards are cited. The place of performance and acceptance is Bethesda, Maryland, at the NIH Clinical Center. The designated point of contact for this procurement is Ryssa Nix, Contract Specialist at the NIH Office of Purchasing and Contracts. This procurement notice does not solicit quotations or bids; rather, it seeks comments to the announcement prior to the closing date. Evaluation factors and formal contract clauses are not detailed due to the simplified acquisition method, and the justification documents reflect certifications supporting the sole-source award to Iron Mountain to ensure continuity and cost-efficiency in managing sensitive patient imaging records.
General Warehousing and Storage

POSTED

6 months ago

DEADLINE

N/A
View Details
NAICS: 561400
Federal
Records Management and Retrieval ServicesThis contract involves the ongoing management of stored physical film records for the National Institutes of Health in Bethesda, focusing on comprehensive indexing, retrieval, and secure return processes. It integrates digital tracking systems to ensure efficient handling and accurate recordkeeping throughout the service lifecycle. The contract falls under NAICS code 561400, which pertains to administrative and support services, and is structured as a subcontract arrangement with the Department of Health and Human Services. The scope emphasizes secure handling procedures to maintain the integrity and confidentiality of records during storage and retrieval. The services are designed to support the agency’s operational needs by providing reliable access to physical films on request, backed by digital advancements that enhance tracking and management capabilities. The contract was posted in mid-January 2026 and is positioned to support NIH’s ongoing information management infrastructure at its Bethesda facility.

POSTED

6 months ago

DEADLINE

N/A
View Details
NAICS: 561990
Federal
Secure Shredding and Destruction of Sensitive MaterialsThis contract involves the secure shredding and destruction of sensitive patient-related materials, including physical film records and documentation. It emphasizes strict adherence to chain-of-custody protocols to ensure the integrity and confidentiality of the materials throughout the process. The contract mandates secure transport and certified destruction methods that comply with applicable privacy regulations, ensuring that all sensitive information is handled and disposed of in a manner that protects patient privacy. The subcontract is issued by the National Institutes of Health, under the Department of Health and Human Services, with the place of performance located in Bethesda, zip code 20892. The chosen NAICS code for this contract is 561990, which relates to specialized waste management services. This contract highlights the importance of regulatory compliance and secure handling procedures in managing sensitive healthcare materials for a federal health agency.
All Other Support Services

POSTED

6 months ago

DEADLINE

N/A
View Details
NAICS: 493110
Federal
Secure Physical Records StorageThis contract involves the long-term storage of over 14,000 linear feet of physical film records that contain sensitive patient information. The storage is required to be climate-controlled to ensure preservation and security of the materials. The scope includes comprehensive inventory management and secure access controls to maintain confidentiality and integrity of the records. The work is performed in Bethesda, with the National Institutes of Health, under the Department of Health and Human Services, overseeing the subcontract. The contract falls under the NAICS code 493110, which pertains to general warehousing and storage services. It was posted on January 16, 2026, and requires adherence to strict security and environmental control standards appropriate for sensitive health-related data. The emphasis is on maintaining secure, organized, and controlled storage to support ongoing compliance with regulatory requirements concerning patient information.
General Warehousing and Storage

POSTED

6 months ago

DEADLINE

N/A
View Details
NAICS: 513210
Federal
ASIT.TO 1 year software support from ArgonSoft (Notice of Intent to sole source)The National Institutes of Health Clinical Center (NIH-CC) intends to award a sole-source, firm-fixed-price contract to ArgonSoft for a 12-month software maintenance and support agreement for the proprietary ASIS.TO Laboratory Information Management System (LIMS). This system, originally developed and installed by ArgonSoft under a prior contract, requires ongoing maintenance including gold-level support, installation of mandatory updates, minor upgrades, and execution of Installation Qualification and Operational Qualification (IQ/OQ) testing. The support services cover up to 200 hours annually, delivered remotely via phone, web, or online HelpDesk, and include bug fixes, urgent incident escalation, system customization (up to 100 hours), consultancy, training, and validation assistance. The place of performance is the NIH Clinical Center in Bethesda, Maryland with the contract period spanning January 1, 2026, through December 31, 2026. This sole-source procurement is justified under FAR 6.302-1 and 13.106-1 due to ArgonSoft’s exclusive ownership and licensing of the ASIS.TO software, making them the only responsible source capable of providing the required customized support and maintenance. Market research confirmed the lack of other qualified vendors. There are no competitive proposals solicited; however, capability statements may be considered if received by the specified deadline. The contract includes no physical packaging or labeling requirements since it involves software support. Inspection and acceptance occur at the NIH site based on adherence to delivery schedules, response times within two business days, and successful completion of IQ/OQ tests. The contract leverages NIH Clinical Center administrative offices for contract administration, though specifics about payment and invoicing mechanisms are not detailed. ArgonSoft is recognized as a small business under NAICS code 513210, and the agreement contains no options beyond the base year. Overall, this acquisition ensures continuity of validated, compliant software support critical to NIH laboratory informatics operations.
Software Publishers

POSTED

6 months ago

DEADLINE

in 3 months
View Details
NAICS: 541519
Federal
Digital-Only Service Delivery – No Physical ComponentsThe contract involves the fully electronic delivery of software maintenance services, emphasizing remote support with no involvement of physical goods, hardware, or materials. All service provisions and support are conducted digitally, ensuring a seamless virtual interaction. This subcontract, issued by the National Institutes of Health under the Department of Health and Human Services, aligns with NAICS code 541519, which relates to computer systems design services. The opportunity was posted on January 12, 2026, with a response deadline set for November 5, 2026. The work is to be performed in Bethesda, with the ZIP code 20814 specified as the place of performance. No set-aside type or specific organization type is indicated, and there is no physical point of contact provided. This contract represents a clear focus on digital service delivery within a government healthcare research context.
Other Computer Related Services

POSTED

6 months ago

DEADLINE

in 3 months
View Details
NAICS: 541512
Federal
Proprietary Software Maintenance and Support for ASIS.TO LIMSThis contract involves a one-year remote maintenance and support agreement for the ASIS.TO Laboratory Information Management System (LIMS). The services required include handling bug fixes, performing system upgrades, configuring the software, conducting validation processes such as Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ), and providing necessary training. All work is mandated to be carried out exclusively by ArgonSoft's internal team, ensuring specialized and consistent service delivery. The contract is managed by the National Institutes of Health, under the Department of Health and Human Services, with the primary place of performance located in Bethesda, Maryland. The solicitation was posted in January 2026, with a response deadline in November 2026. It falls under the NAICS code 541512, which pertains to computer systems design services, and is categorized as a subcontract opportunity. This arrangement supports ongoing reliability and performance of the proprietary LIMS software critical to the client’s laboratory operations.
Computer Systems Design Services

POSTED

6 months ago

DEADLINE

in 3 months
View Details
NAICS: 541618
Federal
Sterility Testing Service (STS) Workflow OptimizationThe contract focuses on enhancing the operational efficiency of the Sterility Testing Service unit by conducting process analysis and implementing system adjustments within the Laboratory Information Management System (LIMS) Portal. Key elements include workflow automation to streamline processes, improvements in reporting capabilities to facilitate better data management, and comprehensive training for users to ensure effective adoption of the updated system. The objective is to optimize the sterility testing workflows to support higher productivity and accuracy. This subcontract is issued by the National Institutes of Health under the Department of Health and Human Services, with performance located in Bethesda. It falls under the NAICS code 541618, which relates to other management consulting services. The contract serves as a critical initiative to modernize the Sterility Testing Service unit’s operations, ensuring that technological and procedural enhancements align with organizational goals for quality and efficiency.
Other Management Consulting Services

POSTED

7 months ago

DEADLINE

N/A
View Details